Achieve Life Sciences (NASDAQ:ACHV) Given Outperform Rating at OppenheimerZolmax • 28 days ago
Oppenheimer restated their outperform rating on shares of Achieve Life Sciences (NASDAQ:ACHV - Free Report) in a research report sent to investors on Monday morning, Benzinga reports. They currently...
Share to Feed
This indicator may be signaling that ACHV's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ACHV stock results show that Achieve Life Sciences beat analyst estimates for earnings per share the fourth quarter of 2023.
The post...
Related Stocks: NAS:ACHV...
Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript...
Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript...
ACHV Aligns with EPS Projections, Focuses on Cytisinicline DevelopmentRelated Stocks: ACHV...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Company to host conference call at 4:30 PM EDT today, Thursday, March 28, 2024SEATTLE and VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV...
Achieve Life Sciences Q4 2023 Earnings Preview...